Saturday - August 9, 2025
Guselkumab Demonstrates Superior Efficacy in Landmark Clinical Trials and Offers New Hope to Crohn's Disease Patients
July 19, 2025
NEW YORK, July 19 (TNSjou) -- Mount Sinai Health System issued the following news release:

* * *

Guselkumab Demonstrates Superior Efficacy in Landmark Clinical Trials and Offers New Hope to Crohn's Disease Patients

Successful clinical trials led to FDA-approval of new biologic treatment.

*

New York, NY (July 17, 2025) - In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Hea . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products